The stock’s fifty day moving average price is $0.49 and its two-hundred day moving average price is $0.69. Organovo has a 52-week low of $0.40 and a 52-week high of $2.05. Get Organovo alerts: ...

Research analysts at StockNews.com assumed coverage on shares of Organovo (NASDAQ:ONVO – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “sell” rating on the ...

Roth Capital Partners is managing the offering. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

S&P 500 funds are inexpensive and share many similarities, but you'll find small differences in cost and how closely they track their benchmark.

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Featured here, the Income Statement (earnings report) for Organovo Holdings Inc, showing the company's financial performance from operating and non operating activities such as revenue ...

Investors in Organovo Holdings, Inc. (NASDAQ:ONVO) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 16, 2019 $1.00... ARK Genomic ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...